Atai Life Sciences (ATAI) Q1 2025 Earnings
ATAI·Reported May 14, 2025·Before market open
Atai Life Sciences reported Q1 2025 revenue of $1.6M. Diluted EPS came in at $-0.15 (+11.8% YoY), beat the $-0.19 consensus by $0.04.
Revenue
$1.6M
Diluted EPS
$-0.15beat by $0.04
Consensus: $-0.19
Financial Snapshot
Trailing eight quarters through Q1 2025
Q1 2025 Earnings FAQ
Common questions about Atai Life Sciences 's Q1 2025 earnings report.
Atai Life Sciences (ATAI) reported Q1 2025 earnings on May 14, 2025 before market open.
Atai Life Sciences reported revenue of $1.6M and diluted EPS of $-0.15 for Q1 2025.
EPS beat the consensus estimate of $-0.19 by $0.04.
Compared to the same quarter a year prior, diluted EPS grew 11.8% from $-0.17.
You can read the 10-Q periodic report (0000950170-25-071435) directly on SEC EDGAR. The filing index links above go to sec.gov.